Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Tropion Breast 02 : Datopotamab Deruxtecan in Advanced or Metastatic ...
Cancer du sein : résultats de l’étude TROPION
TROPION-Breast02: Datopotamab Deruxtecan Preserves Quality of Life in ...
A phase Ib study evaluating the safety and tolerability of durvalumab ...
TROPION-Breast04: a randomized phase III study of neoadjuvant ...
#ESMO23 Dr. Aaron Lisberg presents results from TROPION-Lung01: phase ...
ASCO 2026: TROPION-Urothelial03: A Phase 2/3 Study of Datopotamab ...
Datopotamab Deruxtecan Improves PFS and OS in First-Line Advanced TNBC ...
TROPION-Lung15: a randomized phase III study of osimertinib combined ...
TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and ...
Capsule Summary Slidesets | CCO
First-line datopotamab deruxtecan vs chemotherapy in immunotherapy ...
Full article: TROPION-Breast02: Datopotamab deruxtecan for locally ...
(PDF) TROPION-Breast04: a randomized phase III study of neoadjuvant ...
TROPION-Breast03: a randomized phase III global trial of datopotamab ...
(PDF) TROPION-Breast03: a randomized phase III global trial of ...
Optimizing the Management of Metastatic TNBC: Diagnostics, Treatments ...
TROPION-Lung02: Datopotamab Deruxtecan + Pembrolizumab ± Platinum ...
TROP-2 directed antibody-drug conjugates (ADCs): The revolution of ...
TROPION-PanTumor01 - Slideset Download - Clinical Oncology 2021 ...
The Phase 3 TROPION-Breast01 trial showed Datopotamab Deruxtecan ...
Novel computational pathology-based TROP2 biomarker for datopotamab ...
TROP2 Offers Attractive Therapeutic Target in Breast Cancer and Other ...
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple ...
Full article: TROPION-Lung07: Phase III study of Dato-DXd ...
Results From the Phase II TROPION-Lung05 Study by Jacob Sands et al ...
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated ...
TROPION-Breast01, TROPION-Lung01 Demonstrate PFS Benefit of Datopotamab ...
Datopotamab deruxtecan in patients with untreated, advanced triple ...
Daiichi Sankyo and AstraZeneca's breakthrough combo yields promis...
ESMO 2025: Datopotamab Deruxtecan + Rilvegostomig in Patients with ...
123TiP: TROPION-Lung14: A phase III study of osimertinib ± datopotamab ...
TROPION-Breast01: Datopotamab Deruxtecan Improves Progression-Free Survival
TROPION-Lung02: First-Line Dato-DXd Plus Pembrolizumab With or Without ...
[데일리팜]"유방암 치료 효과 호평"...글로벌제약 ADC신약 가능성
MA13.07 TROPION-Lung02: Initial Results for Datopotamab Deruxtecan Plus ...
TROPION-Breast05: a randomized phase III study of Dato-DXd with or ...
Datopotamab Deruxtecan Plus Pembrolizumab With or Without Platinum ...
TROPION-Lung14 study protocol: a phase III study of osimertinib in ...
Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung ...
17 TROPION-Breast05: A Phase 3 Study of Datopotamab Deruxtecan (Dato ...
TROPION-Breast02 and Dato-DXd: Dr. Hope Rugo on Advancing Care in PD-L1 ...
ASCO GU 2026: TROPION-Urothelial03: A Phase 2/3 Study of Datopotamab ...
第一三共：与化疗相比，靶向TROP2 ADC 一线治疗肺癌3期临床OS改善
记住所有FDA生物药 | 治疗乳腺癌 | TROP2-ADC | Datopotamab Deruxtecan – 肖恩记药
PROs from TROPION-Breast01: datopotamab deruxtecan in HR+/HER2- breast ...
2021 ESMO BC丨袁芃教授：三阴性乳腺癌TROP2靶点药物亮相，未来可期 - 肿瘤瞭望
Frontiers | Advances in Trop-2 targeted antibody-drug conjugates for ...
The TROPION-Breast01 Trial: Datopotamab Deruxtecan in HR+, HER2- Breast ...
Final Survival Outcomes from TROPION-Breast01 Phase 3 Trial of ...
Datopotamab Deruxtecan Shows 14.6-Month Median Survival in Phase 3 ...
TROPION-Lung01研究结果再更新，Dato-DXd为晚期NSCLC患者带来具有临床意义的OS改善_多西_赛组_人群
Pharmaceuticals | Free Full-Text | Progress and Innovative Combination ...
Application based on results from the TROPION-Lung01 phase 3 trial If ...
医药魔方
datopotamab, TROPION-Lung01, patritumab, HERTHENA-Lung01
Trop2 ADC赛道阴云丨AZ肺癌、乳腺癌2项3期失败，科伦产品上市在即 Trop2 ADCTROP2是继HER2之后第二热门的ADC靶点 ...
TROPION-Lung01: Datopotamabe-Deruxtecana versus Docetaxel no Tratamento ...
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced ...
Results from TROPION-Lung05, TROPION-Lung01 Trials Lead to FDA Priority ...
TROPION-Lung02: Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab ...
Troponin complex and three regulatory proteins structure outline ...
Datopotamab deruxtecan versus chemotherapy in previously treated ...
Analysis of Membrane-Bound TROP2 in TROPION-Lung01 Underscores Seminal ...
Abstract OT1-03-05: TROPION-Breast02: Phase 3, open-label, randomized ...
TROP2-directed Antibody-drug Conjugate Approved for Lung Cancer ...
Clinical Impact of TROPION-Breast02: Defining the Role of Datopotamab ...
Tropin (4000 Iu) 1 Pre Filled Injection Price in Pakistan - Uses ...
NCT06350097: TROPION-Lung14 - HKUOC
TROPION-Breast01：Dato-DXd治疗HR+/HER2-转移性乳腺癌的III期临床试验启动医药新闻-ByDrug-一站式医药 ...
TROPION-Lung01 Trial of Datopotamab Deruxtecan Meets PFS End Point in ...
医者论道｜聚焦TROP2 ADC药物，群英共谋HER2阴性晚期乳腺癌治疗新篇章医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
【ESMO ASIA】卢凯华教授：TROPION-Lung05首发亚洲数据，Dato-DXd多项研究夯实夺目临床获益医药新闻-ByDrug-一 ...
Troponin Erhöhung Bedeutung | Troponin-Schnelltest: Durchführung und ...
直击WCLC现场TROP2 ADC研究进展，Dato-DXd联合模式或将成为NSCLC一线治疗新选择_队列_患者_TROPION-Lung
EGFR-Mutated NSCLC (The TROPION-Lung01 Phase III Trial) - Guidelines+ ...
Antibody-drug conjugates targeting TROP-2: Clinical development in ...
继往开来，2024 乳腺癌年度热词公布，开创 ADC 诊疗新时代_腾讯新闻
HR+/HER2- 晚期乳腺癌内分泌耐药新选择｜SABCS 2023_腾讯新闻
8 Datopotamab Deruxtecan (Dato-DXd) in Advanced Triple- Negative Breast ...
Tropin Paediatric Eye Drop 5ml | Uses, Price & Substitutes
Antitumor Activity and Biomarker Analysis for TROP2 Antibody–Drug ...
TROPION-PanTumor03: datopotamab deruxtecan in advanced solid tumors ...
With European Lung Cancer Congress 2026 late-breaking titles out, we ...
OptiTROP-Breast02: Sac-TMT in HR+/HER2- mBC
